Scholars@Duke publication: Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101)

Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101)

Publication , Conference

Raymond, GV; Orchard, P; Aubourg, P; Escolar, ML; Kurtzberg, J; Paedre, S; Balsar, J

Published in: ANNALS OF NEUROLOGY

2013

ANNALS OF NEUROLOGY

1531-8249

0364-5134

2013

S128 / S128

APA

Chicago

ICMJE

MLA

NLM

Raymond, G. V., Orchard, P., Aubourg, P., Escolar, M. L., Kurtzberg, J., Paedre, S., & Balsar, J. (2013). Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101). In ANNALS OF NEUROLOGY (Vol. 74, pp. S128–S128).

Raymond, G. V., P. Orchard, P. Aubourg, M. L. Escolar, J. Kurtzberg, S. Paedre, and J. Balsar. “Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101).” In ANNALS OF NEUROLOGY, 74:S128–S128, 2013.

Raymond GV, Orchard P, Aubourg P, Escolar ML, Kurtzberg J, Paedre S, et al. Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101). In: ANNALS OF NEUROLOGY. 2013. p. S128–S128.

Raymond GV, Orchard P, Aubourg P, Escolar ML, Kurtzberg J, Paedre S, Balsar J. Efficacy and Safety of Hematopoietic Cell Therapy in X-linked Adrenoleukodystrophy: a Multiinstitutional Study (ALD-101). ANNALS OF NEUROLOGY. 2013. p. S128–S128.

ANNALS OF NEUROLOGY

1531-8249

0364-5134

2013

S128 / S128